Overview

A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery

Status:
Recruiting

Trial end date:
2023-04-23

Target enrollment:

Participant gender:

Summary

This is an open-label, multicenter study evaluating the dose, effect, safety and tolerability of intravenous PDNO infusion given to patients undergoing cardiopulmonary bypass (CPB) surgery with post-operative acute pulmonary hypertension (aPH).

Phase:

Phase 2

Details

Lead Sponsor:

Attgeno AB

Collaborator:

Scandinavian CRO AB